Literature DB >> 9203171

Distribution of alpha-integrin subunits in fetal polycystic kidney diseases.

F Daïkha-Dahmane1, F Narcy, M Dommergues, M Lacoste, A Beziau, M C Gubler.   

Abstract

An alteration in cell/matrix interactions is one of the suggested mechanisms leading to cyst formation in polycystic kidney diseases. Most of these interactions are mediated by beta 1-integrins, a subfamily of integrin receptors, formed by the association of the beta 1-chain with different alpha-subunits. To date, no study on alpha-integrin subunit distribution during the early stages of cyst development has been reported. Using immunofluorescence, we analyzed the distribution of alpha-integrin subunits (alpha 1, alpha 2, alpha 3, alpha 5, and alpha 6) and basement membrane proteins in kidneys of fetuses with autosomal dominant (ADPKD) or autosomal recessive polycystic kidney disease (ARPKD). The distribution was compared with that observed in normal fetal and post-natal kidneys, and in fetal cystic dysplasia and Meckel syndrome. Marked increase in alpha 1-integrin staining was observed in normal and cystic collecting duct cells of both polycystic diseases (PKD), compared with normal and cystic controls. The distribution of integrin subunits alpha 2, alpha 3, and alpha 6 was irregular in cyst epithelial cells of PKD and cystic controls. The increased expression of the alpha 1-subunit specifically observed in PKD collecting duct cells may be an early consequence of the genetic defect in ARPKD. In ADPKD it parallels the reported expression of polycystin, the protein product of PKD1. The irregular expression of alpha 2, alpha 3, and alpha 6 integrin subunits observed in all types of cysts suggests that cell/matrix interactions are altered early and may participate in the development of cysts, perhaps by contributing to the deregulation of cell survival in cystic diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203171     DOI: 10.1007/s004670050275

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  9 in total

1.  Regulation of integrin expression by Gα12: An additional potential mechanism modulating cell attachment.

Authors:  Tianqing Kong; Daosong Xu; Mei Tran; Bradley M Denker
Journal:  Cell Adh Migr       Date:  2010-07-01       Impact factor: 3.405

2.  Inactivation of integrin-β1 prevents the development of polycystic kidney disease after the loss of polycystin-1.

Authors:  Kyung Lee; Sylvia Boctor; Laura M C Barisoni; G Luca Gusella
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

Review 3.  Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

4.  Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.

Authors:  Archana Raman; Gail A Reif; Yuqiao Dai; Aditi Khanna; Xiaogang Li; Lindsay Astleford; Stephen C Parnell; James P Calvet; Darren P Wallace
Journal:  J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 10.121

Review 5.  Extracellular matrix, integrins, and focal adhesion signaling in polycystic kidney disease.

Authors:  Yan Zhang; Gail Reif; Darren P Wallace
Journal:  Cell Signal       Date:  2020-04-18       Impact factor: 4.315

6.  Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins.

Authors:  Y Huan; J van Adelsberg
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  Abnormalities in focal adhesion complex formation, regulation, and function in human autosomal recessive polycystic kidney disease epithelial cells.

Authors:  Sharon Israeli; Kurt Amsler; Nadezhda Zheleznova; Patricia D Wilson
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-18       Impact factor: 4.249

8.  Modulation of the secretory pathway rescues zebrafish polycystic kidney disease pathology.

Authors:  Stéphanie Le Corre; David Eyre; Iain A Drummond
Journal:  J Am Soc Nephrol       Date:  2014-03-13       Impact factor: 10.121

Review 9.  Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling.

Authors:  Xia Zhou; Vicente E Torres
Journal:  Front Mol Biosci       Date:  2022-09-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.